BioArctic AB (LTS:0RV2) Other Current Liabilities: kr653 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RV2 BioArctic AB LTS:0RV2
56 GF Score
Price kr334.30
! 7 Warning Signs
View Full Analysis

What is BioArctic AB Other Current Liabilities?

BioArctic AB LTS:0RV2 56 Other Current Liabilities is kr653 Mil as of Jun. 2026. GuruFocus rates LTS:0RV2 with a GF Score™ of 56/100. The stock has 7 warning signs investors should review.

BioArctic AB's other current liabilities for the quarter that ended in Jun. 2026 was kr653 Mil.

BioArctic AB's quarterly other current liabilities increased from Dec. 2025 (kr344 Mil) to Mar. 2026 (kr381 Mil) and increased from Mar. 2026 (kr381 Mil) to Jun. 2026 (kr653 Mil).

BioArctic AB's annual other current liabilities increased from Dec. 2023 (kr59 Mil) to Dec. 2024 (kr78 Mil) and increased from Dec. 2024 (kr78 Mil) to Dec. 2025 (kr344 Mil).

BioArctic AB Other Current Liabilities Related Terms

BioArctic AB Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for BioArctic AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioArctic AB Other Current Liabilities Chart

BioArctic AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.36 40.54 58.51 78.48 344.40

BioArctic AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 244.60 585.25 344.40 381.45 653.15
LTS:0RV2
56GF Score
BioArctic AB LTS:0RV2
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioArctic AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr653 Mil mean?
BioArctic AB (LTS:0RV2) has a Other Current Liabilities of kr653 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on BioArctic AB.
Is BioArctic AB's Other Current Liabilities too high?
BioArctic AB's current Other Current Liabilities is kr653 Mil. Overall, BioArctic AB has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's Other Current Liabilities compare to VRTX and REGN?
BioArctic AB's Other Current Liabilities of kr653 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on BioArctic AB. BioArctic AB's current Other Current Liabilities is kr653 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
BioArctic AB (LTS:0RV2) has a current Other Current Liabilities of kr653 Mil. The current Other Current Liabilities is kr653 Mil. BioArctic AB's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For BioArctic AB (LTS:0RV2), the current Other Current Liabilities is kr653 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
56GF Score

Get the complete analysis for LTS:0RV2

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr334.30
Price